Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shandong Baolai-Leelai Bio-Industrial Group is a leading Chinese high-tech enterprise specializing in the research, development, and manufacturing of animal micro-ecological preparations. Founded in 1996 and headquartered in Tai'an, the company focuses on probiotics, enzyme preparations, and biological vaccines for livestock, poultry, and aquaculture. It operates one of the largest probiotic production bases in Asia and maintains a strong emphasis on bio-safety and antibiotic-free solutions for the global agricultural industry. The group's product portfolio includes feed additives, environmental treatment agents, and animal health supplements designed to improve immunity and growth performance. Baolai-Leelai is recognized for its advanced microbial fermentation and stabilization technologies, supported by a dedicated research institute and numerous academic collaborations.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shandong Baolai-Leelai Bio-Industrial Group.